However, clinical results of EGFR monoclonal antibodies both as monotherapy and in combination with PBC in ESCC have been similar to those demonstrated with EGFR TKis [10, 18, 20–23, 27, 28, 35]. The gene discussed is EGFR; the disease is esophageal squamous cell carcinoma.